PRA Health Sciences, Inc. (PRAH): Price and Financial Metrics
PRA Health Sciences, Inc. (PRAH)
Today's Latest Price: $121.86 USD
Updated Jan 27 4:00pm
Add PRAH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 64 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
PRAH Stock Summary
- PRAH has a market capitalization of $8,222,057,564 -- more than approximately 80.69% of US stocks.
- PRA Health Sciences Inc's stock had its IPO on November 14, 2014, making it an older stock than just 21.57% of US equities in our set.
- The volatility of PRA Health Sciences Inc's share price is greater than that of merely 21.79% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to PRAH, based on their financial statements, market capitalization, and price volatility, are WMS, EXLS, TTEK, CRL, and G.
- PRAH's SEC filings can be seen here. And to visit PRA Health Sciences Inc's official web site, go to prahs.com.
PRAH Stock Price Chart Interactive Chart >
PRAH Price/Volume Stats
| Current price | $121.86 | 52-week high | $137.88 |
| Prev. close | $128.17 | 52-week low | $58.67 |
| Day low | $120.75 | Volume | 279,841 |
| Day high | $125.88 | Avg. volume | 291,688 |
| 50-day MA | $120.41 | Dividend yield | N/A |
| 200-day MA | $105.51 | Market Cap | 7.82B |
PRA Health Sciences, Inc. (PRAH) Company Bio
PRA Health Sciences provides various product development services for pharmaceutical and biotechnology companies worldwide. The company was founded in 1976 and is based in Raleigh, North Carolina.
PRAH Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $121.86 | $162.08 | 26% |
We started the process of determining a valid price forecast for PRA Health Sciences Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that PRA Health Sciences Inc ranked in the 57th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for PRA Health Sciences Inc ended up being:
- In the past 4.7 years, PRA Health Sciences Inc has a compound free cash flow growth rate of 0.28%; that's better than 62.74% of cash flow producing equities in the Healthcare sector, where it is classified.
- PRA Health Sciences Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 24.81% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 24% |
| 1% | 25% |
| 2% | 26% |
| 3% | 28% |
| 4% | 29% |
| 5% | 30% |
Want more companies with a valuation profile/forecast similar to that of PRA Health Sciences Inc? See HBIO, CHE, JAZZ, SNY, and UTHR.
Loading social stream, please wait...